Physician profile
Maria Vargas
NPI 1316263817
$1,092.49
in general payments reported to CMS, 2019-2025
11 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $95.51 · 2021: $33.85 · 2022: $64.35 · 2023: $250 · 2024: $379 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728 · Travel and Lodging: $37.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $728.11 |
| Travel and Lodging | $37.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $321.91 | 2019-2025 | Stratafix, Vistaseal, Harmonic |
| Sumitomo Pharma America, INC. | $303.44 | 2023-2024 | Myfembree |
| Coopersurgical, INC. | $115.75 | 2024 | Wallach Cryosurgical Equipment |
| Hologic Sales and Service, LLC | $105.51 | 2019-2023 | Coolseal Generator |
| Myovant Sciences INC. | $64.35 | 2022 | |
| Abbvie INC. | $50.73 | 2020 | |
| Intuitive Surgical, INC. | $37.00 | 2025 | |
| Pfizer INC. | $35.42 | 2021-2024 | |
| Astellas Pharma US INC | $20.60 | 2024 | Veozah |
| Meditrina | $19.99 | 2025 | |
| Coloplast Corp | $17.79 | 2023 | Saffron |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Vargas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.